Practical Use of Angiotensin I/II (1-5) in RAS Research

What This Product Solves

Angiotensin I/II (1-5) is a standardized peptide fragment composed of the first five amino acids (Asp-Arg-Val-Tyr-Ile) of the angiotensin I and II sequences. This product is designed for researchers studying the renin-angiotensin system (RAS), which is central to blood pressure regulation and fluid balance. The peptide acts as a vasoconstrictor and stimulates aldosterone release, making it suitable for modeling hypertension, assessing renal function, and dissecting aldosterone signaling pathways. Its defined sequence and solid-state stability enable reproducible experimental design in cardiovascular and renal research workflows, where precise control over peptide inputs is critical (product_spec).

For additional guidance on implementation in hypertension research, see the Practical Guide to Angiotensin I/II (1-5) in Hypertension Research, which details suitability and workflow boundaries. For more focused technical use within RAS modeling, refer to the Technical Use of Angiotensin I/II (1-5) in RAS Workflows.

Protocol Parameters

• assay: Peptide stock preparation | value_with_unit: 66.5 mg/mL in DMSO; 69.5 mg/mL in ethanol | applicability: Required for all in vitro and ex vivo dosing applications | rationale: Angiotensin I/II (1-5) is insoluble in water, necessitating use of organic solvents at specified concentrations for reproducibility and peptide stability | source_type: product_spec
• assay: Storage conditions | value_with_unit: -20°C (solid form, desiccated) | applicability: All workflows requiring multi-use aliquots or stock longevity | rationale: Low-temperature storage preserves peptide integrity and prevents degradation over time | source_type: product_spec
• assay: Solvent compatibility check | value_with_unit: DMSO or ethanol only | applicability: Essential prior to peptide dilution into assay buffer or vehicle | rationale: Prevents precipitation and inconsistent dosing due to peptide's insolubility in aqueous media | source_type: workflow_recommendation

Workflow Setup and QC Checklist

For consistent and reproducible results when using Angiotensin I/II (1-5) in RAS research, the following steps are recommended:

• Solid handling: Weigh the peptide accurately using an analytical balance in a low-humidity environment to prevent moisture uptake before dissolution.
• Dissolution: Add the peptide to DMSO or ethanol at concentrations not exceeding the solubility limits (66.5 mg/mL in DMSO, 69.5 mg/mL in ethanol). Vortex or gently sonicate to ensure complete dissolution.
• Aliquoting: Divide the fully dissolved stock into single-use aliquots to avoid repeated freeze-thaw cycles, which can reduce peptide activity.
• Storage: Store aliquots at -20°C, protected from light and moisture. Use desiccant packs in storage containers if possible.
• Pre-assay QC: Inspect each aliquot for precipitation or cloudiness before use. Discard any aliquots showing visual signs of instability.
• Vehicle controls: Always include matched solvent controls in assays to account for any DMSO or ethanol effects.

Common Failure Modes and Fixes

• Precipitation upon dilution: If precipitation occurs when diluting the peptide stock into aqueous buffers, verify that the initial stock was within solubility limits and that the dilution is performed into compatible vehicles. Gradually add the stock to buffer under gentle agitation, or increase the percentage of DMSO/ethanol in the final solution if assay parameters permit.
• Loss of activity: Decreased peptide activity may result from repeated freeze-thaw cycles or improper storage. Use single-use aliquots and maintain storage at -20°C as recommended.
• Solvent interference: Elevated DMSO or ethanol concentrations can affect cell viability or assay readouts. Minimize final solvent concentrations in the assay and validate solvent compatibility in pilot studies.
• Analytical variability: Inconsistent results can arise from inaccurate peptide weighing or incomplete dissolution. Calibrate balances regularly and confirm homogeneity of peptide solutions prior to use.

Scope and Limitations

Angiotensin I/II (1-5) is intended for research on the renin-angiotensin system, specifically within contexts involving blood pressure regulation, aldosterone release, and cardiovascular or renal signaling pathways. Its application is unsuitable for unrelated peptide signaling studies or off-target mechanistic explorations due to its defined biochemical activity and solubility constraints (Technical Guide for Research Workflows). The product is not designed for clinical use, diagnostic applications, or peptide modeling outside RAS-associated pathways. Researchers should avoid using this peptide in workflows dependent on aqueous solubility or requiring broad-spectrum peptide activity.

Conclusion

Angiotensin I/II (1-5) offers a reliable, well-characterized Asp-Arg-Val-Tyr-Ile peptide for controlled studies of the renin-angiotensin system, hypertension, and aldosterone signaling. By adhering to recommended handling, solubility, and storage protocols, researchers can ensure reproducibility and technical accuracy in cardiovascular and renal investigations. For full product details and ordering information, refer to the Angiotensin I/II (1-5) product page from APExBIO.